Endurant Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.77M | Buy |
|
|||||
|
2022
Q1 | $2.32M | Buy |
|
|||||
|
2021
Q4 | $2.18M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $4.43M | Buy |
|
|||||
|
2021
Q1 | $1.11M | Sell |
|
|||||
|
2020
Q4 | $6.05M | Buy |
|
|||||
|
2020
Q3 | $2.25M | Sell |
|
|||||
|
2020
Q2 | $2.09M | Buy |
|
|||||
|
2020
Q1 | $905K | Sell |
|
|||||
|
2019
Q4 | $2.64M | Sell |
|
|||||
|
2019
Q3 | $2.59M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $3.33M | Buy |
|
|||||
|
2018
Q2 | $936K | Sell |
|
|||||
|
2018
Q1 | $1.52M | Sell |
|
|||||
|
2017
Q4 | $3.4M | Buy |
|
|||||
|
2017
Q3 | $1.08M | Buy |
|